Adriana Raffin Pohlmann
Overview
Explore the profile of Adriana Raffin Pohlmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
811
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
da Silva E, Pedraca E, Salgueiro A, Gazzi R, Nunes J, Cavagni J, et al.
Nanomedicine
. 2024 Aug;
62:102779.
PMID: 39147219
Actinic cheilitis (AC) is a lip disorder, with no standard treatment. Imiquimod (IMIQ) is an immunomodulator that treat precancerous lesions; however, its commercial form causes severe adverse effects. This study...
2.
Keingeski M, Longo L, Brum da Silva Nunes V, Figueiro F, Dallemole D, Pohlmann A, et al.
Metab Syndr Relat Disord
. 2024 Mar;
22(5):394-401.
PMID: 38498801
Extracellular vesicles (EVs) are promising as a biomarker of metabolic dysfunction associated steatotic liver disease (MASLD). The objective is to study EVs and their involvement in MASLD concerning the disease's...
3.
de Cristo Soares Alves A, Dallemole D, Medeiro Ciocheta T, Weber A, da Silva Gundel S, Visioli F, et al.
Int J Pharm X
. 2024 Jan;
6:100193.
PMID: 38204452
Nanoencapsulation of chemotherapeutics, including doxorubicin, can endow the formulations with unique properties, such as a decrease in adverse effects and toxicity. The chicken embryo model is an alternative and well-accepted...
4.
5.
de Mello Palma V, Frank L, Balinha D, Rados P, Pohlmann A, Guterres S, et al.
Br J Clin Pharmacol
. 2023 Oct;
90(2):427-439.
PMID: 37817570
Imiquimod (IMQ) is a chemotherapeutic and immunostimulant drug that is applied topically, demonstrating antitumor and antiviral activities. The objective of this review was to compile data on the off-label use...
6.
de Castro Leao M, di Piazza I, Caria S, Broering M, Farsky S, Uchiyama M, et al.
Biomed Pharmacother
. 2023 Sep;
167:115474.
PMID: 37741249
Background: Omega 3 fatty acids, such as docosahexaenoic acid (DHA) have been widely consumed as supplements to control chronic inflammation. Nanocapsules containing DHA (MLNC-DHA-a1) were developed and showed excellent stability....
7.
Urena N, de Oliveira C, Guterres S, Pohlmann A, da Costa O, Boechat A
Molecules
. 2023 Jul;
28(13).
PMID: 37446881
Diclofenac is the most prescribed nonsteroidal anti-inflammatory drug worldwide and is used to relieve pain and inflammation in inflammatory arthritis. Diclofenac is associated with serious adverse effects, even in regular-dose...
8.
Bubols G, Arbo M, Peruzzi C, Cestonaro L, Altknecht L, Fao N, et al.
Environ Sci Pollut Res Int
. 2022 Dec;
30(13):36405-36421.
PMID: 36547826
This study characterized and investigated the toxicity of two multi-walled carbon nanotubes (MWCNT) NM-401 and NM-403 at 60 and 180 µg after four repeated intratracheal instillations; follow-up times were 3,...
9.
Broering M, de Castro Leao M, da Rocha G, Scharf P, Xavier L, de Cristo Soares Alves A, et al.
Eur J Pharm Biopharm
. 2022 Nov;
181:49-59.
PMID: 36334840
Annexin A1 (AnxA1), a 37KDa protein, is secreted by inflammatory and epithelial cells and displays anti-inflammatory and wound healing activities in intestinal bowel diseases. Herein, we aimed to functionalize recombinant...
10.
Frank L, Gazzi R, Pohlmann A, Guterres S, Contri R
Skin Pharmacol Physiol
. 2022 Jun;
35(5):291-298.
PMID: 35705070
Introduction: Sunscreens are substances applied on the skin surface to protect the skin from the harmful effects of UV light. Nanoparticles can increase the retention time of the sunscreen on...